AdobeStock_402341804

Investment Thesis

We target oncology, neurosciences, rare disease, and antimicrobial resistance. In addition to targeting these disease states with patients in need, we look for biotech and medtech companies dramatically changing how medicine is practiced. We have a particular interest in supporting companies with disruptive technologies in cell and gene therapy, gene editing, and mRNA/RNAi, all technologies.

Portfolio Companies

Kineticos works with companies at all stages of their life cycle, from start-up to commercialization.

View All

What Portfolio Companies Are Saying

"The support from Kineticos Ventures and their network has been crucial for Inceptor Bio. The broader Kineticos network has helped with a number of specific projects that have helped shape the direction of the company. We are grateful to have such truly invested investors!"
Inceptor Bio Management Team
"We have appreciated the input from Kineticos as hands on and supportive investors. Frank and the team have been helpful in making introductions and leveraging their network."
Dr James McIlroy MBChB BMedSci (Hons) | CEO, EnteroBiotix
"Since the early days of Promaxo, Kineticos has been an important ally. They have consistently focused on our needs and helped us advance our innovative modular MRI platform. Kineticos’ business and scientific acumen has resonated with our team."
Dr. Amit Vohra | Founder and CEO, Promaxo

New From Kineticos

View All

Partner With Us to Accelerate Your Next Venture

Contact Us